# STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients

> **NCT00642850** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 188 (actual)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** methoxy polyethylene glycol-epoetin beta [Mircera]

## Key facts

- **NCT ID:** NCT00642850
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 188 (ACTUAL)
- **Last updated:** 2016-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00642850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00642850, "STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00642850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*